Euroscreen 2: towards community policy on insurance, commercialization and public awareness.
The project Euroscreen 2 has examined genetic screening and testing with particular reference to implications for insurance, commercialization through marketing of genetic tests direct to the public, and issues surrounding raising public awareness of these and other developments in genetics, including the practical experiment of a Gene Shop. This paper provides a snapshot of the three year project. The study group's work included monitoring developments in different European countries and exploring possibilities for regulation in insurance and commercialization together with public attitudes to regulation. The success or failure of different strategies is not independent of public awareness. Exploration of policy, however, also requires examination of fundamental concepts such as solidarity and geneticization.
Chadwick
R
R
Lancaster University, United Kingdom. r.chadwick@lancaster.ac.uk
ten Have
H
H
Hoedemaekers
R
R
Husted
J
J
Levitt
M
M
McGleenan
T
T
Shickle
D
D
Wiesing
U
U
D001294:Attitude to Health; D001364:Awareness; D003132:Commerce; D005060:Europe; D033142:Genetic Services; D005820:Genetic Testing / Q000191:economics* / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007348:Insurance, Health; D011050:Policy Making; D017149:Private Sector; D011639:Public Opinion; D011640:Public Policy